Research by Andrea and Lawrence A. Wolfe Research Professor Melissa Elafros, M.D., Ph.D., found that though it is a widespread disorder, neuropathy often goes undiagnosed, new research shows, leaving many people at risk of falls, infection, and even amputation.
For ALS Awareness Month, WCMU radio spoke to Eva Feldman, M.D., Ph.D., about the latest on amyotrophic lateral sclerosis (ALS).
In honor of ALS Awareness Month, the team and supporters of the ALS Center of Excellence shared their takes on the impact of amyotrophic lateral sclerosis (ALS).
The ALS Association, American Academy of Neurology (AAN), and American Brain Foundation awarded the 2024 Sheila Essey Award to Eva Feldman, M.D., Ph.D., at the AAN's annual meeting in April.
The Michigan Medicine blog covered research published by Frances and Kenneth Eisenberg Emerging Scholar Kevin Chen, M.D., found that stem cells improved some memory and reduced inflammation when injected into a preclinical Alzheimer's disease model.
The Eisenberg Emerging Scholar received NIH’s coveted Mentored Research Scientist Career Development Award, furthering her work to better understand the mechanisms of diabetic neuropathy.
Eva Feldman, M.D., Ph.D., James W. Albers Distinguished University Professor of Neurology, was part of a research group that published insights into the role gender plays in the everyday experiences of women clinician scientists and the related barriers they face.
Stephanie Eid, Ph.D., led a research team that examined gene expression at two different injury sites in peripheral neuropathy to identify new therapy targets, publishing their findings in Translational Research .
Featured on the cover and in a subsequent story of the American Academy of Neurology's Neurology Today , Dr. Eva Feldman explored the environmental triggers of neurodegenerative disease.
Michigan Medicine's Health Lab covered new research about how residential exposure to toxins is associated with ALS risk.
The University of Michigan's independent, student-run newspaper covered the latest research happening at the ALS Center of Excellence.
Recently published research by Dr. Brian Callaghan looking at whether influenza or COVID had a higher neurological burden was covered by U.S. News & World Report, Daily Mail , Science Magazine, Drugs.com and many more.
Kevin Chen M.D., and Stephanie Eid, Ph.D., have been named the inaugural Frances and Kenneth Eisenberg Emerging Scholars at the NeuroNetwork for Emerging Therapies.
The Zambia Cohort of Healthy Aging and Dementia Study (Z-CHAD) was launched by Andrea and Lawrence A. Wolfe Research Professor Melissa Elafros, M.D., Ph.D., to understand the true impact of dementia on patients in Zambia and their caregivers.
Brian Callaghan, M.D., M.S., authored research published in Neurology , the official journal of the American Academy of Neurology, that answered just that.
The Center to Accelerate Population Research in Alzheimer's (CAPRA) featured Andrea and Lawrence A. Wolfe Research Professor Melissa Elafros, M.D., Ph.D., in the CAPRA Quarterly Winter 2024 edition.
Pranger ALS Clinic Director Stephen Goutman, M.D., M.S., was interviewed by the Canadian media organization about this recent publication on ALS recreational risk.
Recent research by Drs. Stephen Goutman and Eva Feldman showed that certain activities, such as golfing and gardening, may represent modifiable risk factors for ALS.
In the journal Academic Medicine, Eva Feldman, M.D., Ph.D., was an author of the study “The Disproportionate Effects of the COVID-19 Pandemic on the Time Allocation of Recipients of NIH Career Development Awards Who Are Women or Caregivers of Dependents.”
Michigan Medicine's Health Lab covered recent research that showed that certain activities such as golfing and gardening may represent modifiable risk factors for ALS.
